Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Enzalutamide: Phase II started

Medivation began an open-label, international Phase II trial to evaluate 160 mg

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE